AbbVie Inc. (ABBV) vs PepsiCo, Inc. (PEP)
A side-by-side comparison of AbbVie Inc. and PepsiCo, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; PEP is classified in Consumer Defensive. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
PEP
PepsiCo, Inc.
$142.86Consumer DefensiveDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABBV vs PEP
growth of $100 · dividends reinvested · last 14yABBV +1164.7%PEP +198.6%ABBV compounded faster
ABBV PEP
ABBV vs PEP: by the numbers
- •ABBV is the larger company ($465.51B vs $195.15B market cap).
- •PEP trades at the lower trailing earnings multiple (18.32 vs 125.98 P/E), one valuation lens rather than an overall verdict.
- •PEP converts more revenue to profit (10.82% vs 5.79% net margin).
- •PEP grew revenue faster over the past five years (5.37% vs 4.59% CAGR).
- •PEP pays the higher dividend yield (4.11% vs 2.62%).
Metrics side by side
Valuation
| Metric | ABBV | PEP |
|---|---|---|
| P/E ratio | 125.98 | 18.32 |
| Forward P/E | N/A | 16.34 |
| P/S ratio | 7.26 | 1.97 |
| P/B ratio | 16.57 | 8.66 |
| PEG ratio | N/A | 7.63 |
| EV / EBITDA | 20.46 | 12.43 |
| FCF yield | 4.58% | 4.85% |
Profitability
| Metric | ABBV | PEP |
|---|---|---|
| Gross margin | 70.68% | 53.96% |
| Operating margin | 27.60% | 14.96% |
| Net margin | 5.79% | 10.82% |
| ROE | 13.23% | 47.45% |
| ROIC | 12.97% | 13.29% |
Dividends
| Metric | ABBV | PEP |
|---|---|---|
| Dividend yield | 2.62% | 4.11% |
| Payout ratio | 284.39% | 95.32% |
Growth (annualized)
| Metric | ABBV | PEP |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 5.37% |
| EPS CAGR (5Y) | -2.79% | 2.40% |
| FCF CAGR (5Y) | 3.24% | 5.40% |
| Total return CAGR (5Y) | 21.24% | 0.72% |
Frequently asked
- Which has the lower trailing P/E, ABBV or PEP?
- PEP has the lower trailing P/E: ABBV trades at 125.98 and PEP at 18.32. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or PEP?
- Over the past five years, PEP grew revenue faster — ABBV at a 4.59% CAGR versus PEP at 5.37%.
- Does ABBV or PEP pay a bigger dividend?
- ABBV yields 2.62% and PEP yields 4.11% based on trailing dividends and the latest price.
- Is ABBV or PEP more profitable?
- PEP runs the higher net margin — ABBV at 5.79% versus PEP at 10.82%.
- How have ABBV and PEP total returns compared?
- Over the past 10 years, ABBV delivered 19.57% and PEP delivered 5.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioPepsiCo P/E ratioAbbVie dividend yieldPepsiCo dividend yieldAbbVie ROEPepsiCo ROEAbbVie operating marginPepsiCo operating marginAbbVie revenue growthPepsiCo revenue growthAbbVie free cash flowPepsiCo free cash flow
AbbVie & PepsiCo appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.